A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility

NCT02835469 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 412

Last updated 2019-03-28

No results posted yet for this study

Summary

The purpose of this study is to investigate the ongoing pregnancy rates at 10-11 weeks after embryo transfer in patients treated with Menopur® Multidose

Conditions

Interventions

DRUG

Menotrophin

Sponsors & Collaborators

  • Ferring Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Clinical Development Support · Ferring Pharmaceuticals

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-06-30
Primary Completion
2019-02-01
Completion
2019-02-01

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02835469 on ClinicalTrials.gov